Uranium Royalty
UROY
4.19
-0.05
-1.18%
Uranium Royalty
US · UROY
#2972 by market cap
Listed 1970
4.19
-0.05
-1.18%
Live - 5344 symbols - heartbeat 538s ago
· 2026-10-08 06:33
Pre-market
4.30
+2.63%
After-hours
4.34
+3.49%
- Market cap
- 1.60B
- P/E (TTM)i
- 11.03
- P/Bi
- 1.68
- EPSi
- 0.29
- Div yieldi
- 0.00%
- 52W posi
- 55%
Reader sentiment
Are you bullish or bearish on UROY?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Margins
- Gross margin
- 30.63%
- Operating margin
- 27.09%
- Net margin
- 21.53%
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0 | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | 0 | 2.06M | 10.78M | 2.62M | 57.26M |
| Selling & admin expenses | 896.57K | 1.56M | 1.04M | 3.80M | 4.47M | 4.97M | 4.80M | 5.29M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -996.49K | -1.64M | -1.20M | -4.24M | -2.77M | 5.09M | -3.44M | 50.65M |
| Pretax profit | -3.02M | -2.04M | -1.51M | -4.98M | -4.29M | 16.90M | -5.64M | 54.64M |
| Tax | -186.05K | -92.33K | -389.34K | -1.69M | -10.98K | 3.20M | -1.14M | 14.39M |
| Net profit | -2.84M | -1.95M | -1.12M | -3.29M | -4.28M | 13.71M | -4.51M | 40.25M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | -0.04 | -0.02 | -0.04 | -0.04 | 0.12 | -0.04 | 0.29 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | 635.54K | 3.58M | 8.58K | 3.50M | 49.86M | 17.37M |
| Selling & admin expenses | 469.51K | 1.33M | 2.11M | 1.32M | 291.20K | 964.00K |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -804.45K | 2.25M | -2.31M | 2.15M | 48.61M | 16.41M |
| Pretax profit | -2.73M | 1.40M | 1.26M | 1.18M | 51.10M | 23.09M |
| Tax | -1.33M | 379.00K | -213.13K | -260.53K | 14.91M | 6.83M |
| Net profit | -1.41M | 1.03M | 1.47M | 1.44M | 36.18M | 16.25M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.01 | 0.01 | 0.01 | 0.01 | 0.26 | 0.10 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 22.97M | 31.27M | 41.22M | 103.57M | 101.65M | 169.56M | 172.59M | 329.30M |
| Cash & ST investments | 22.84M | 30.48M | 30.35M | 43.41M | 38.55M | 22.13M | 14.55M | 254.34M |
| Inventory | -- | 0 | 10.10M | 57.98M | 62.65M | 136.88M | 157.62M | 34.33M |
| Total assets | 33.15M | 50.92M | 62.05M | 137.68M | 136.03M | 203.91M | 216.12M | 373.32M |
| Total current liabilities | 11.11M | 287.94K | 412.96K | 375.55K | 7.57M | 2.02M | 739.00K | 55.48M |
| Short-term debt | 10.21M | -- | -- | 13.14K | 7.17M | 27.07K | 39.00K | 44.00K |
| Long-term debt | -- | 28.83K | 32.58K | 10.01M | -- | -- | -- | -- |
| Total liabilities | 11,114,124.34 | 316,766.60 | 445,541.33 | 10,460,470.90 | 7,628,496.12 | 2,132,033.92 | 1,016,000.00 | 60,550,000.00 |
| Total equity | 22.04M | 50.60M | 61.61M | 127.22M | 128.40M | 201.78M | 215.10M | 312.77M |
| Retained earnings | -3.08M | -4.93M | -6.42M | -9.38M | -8.68M | 16.48M | 12.21M | 52.45M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 172.59M | 173.18M | 195.00M | 238.00M | 329.30M | 120.79M |
| Cash & ST investments | 14.55M | 35.50M | 58.88M | 101.84M | 254.34M | 65.07M |
| Inventory | 157.62M | 137.24M | 135.81M | 135.70M | 34.33M | 220.00K |
| Total assets | 216.12M | 215.74M | 237.14M | 280.66M | 373.32M | 1.91B |
| Total current liabilities | 739.00K | 858.47K | 733.78K | 731.69K | 55.48M | 138.04M |
| Short-term debt | 39.00K | 41.22K | 41.48K | 43.30K | 44.00K | 57.14M |
| Long-term debt | -- | -- | -- | -- | -- | 535.66M |
| Total liabilities | 1,016,000.00 | 959,000.21 | 823,183.60 | 1,027,447.53 | 60,550,000.00 | 819,508,000.00 |
| Total equity | 215.10M | 214.79M | 236.32M | 279.63M | 312.77M | 1.09B |
| Retained earnings | 12.21M | 13.56M | 14.88M | 16.71M | 52.45M | 68.70M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.09M | -1.79M | -11.17M | -53.17M | -8.39M | -76.43M | -15.06M | 178.46M |
| Depreciation & amortization | -- | -- | 0 | 1.55K | 17.57K | 0 | 47.00K | 111.00K |
| Free cash flow | -1.62M | -4.44M | -11.17M | -63.79M | -9.98M | -76.49M | -23.40M | 177.69M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | -- | -- | -- |
| Stock buybacks / issuance | 12.58M | 23.03M | 4.41M | 44.61M | 10.41M | 51.94M | 0 | 52.92M |
| Ending cash balance | 1.66M | 8.53M | 5.88M | 3.39M | 10.47M | 15.39M | 9.45M | 282.04M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.12M | 23.41M | -3.04M | 6.50M | 151.58M | 52.97M |
| Depreciation & amortization | -4.74K | 31.00K | 40.52K | 31.96K | 7.52K | 188.00K |
| Free cash flow | 1.78M | 22.65M | -3.02M | 6.48M | 151.58M | 52.97M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 4.00K | 20.11M | 33.43M | -630.57K | 256.00K |
| Ending cash balance | 9.45M | 6.56M | 51.87M | 91.13M | 282.04M | 103.65M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -12.88 | -5.36 | -2.00 | -3.48 | -3.35 | 4.33 | -1.97 | 15.30 |
| ROA %i | -8.56 | -4.63 | -1.99 | -3.29 | -3.13 | 4.21 | -1.96 | 13.70 |
| ROIC %i | -0.84 | -3.38 | -2.06 | -2.96 | -2.30 | 4.02 | -2.11 | 14.74 |
| 5-year avg ROE %i | -- | -- | -- | -- | -5.41 | -1.18 | -0.54 | 2.91 |
| EBIT margin %i | -- | -- | -- | -- | -30.48 | 18.18 | -33.92 | 29.23 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | 95.05 |
| Current ratioi | 2.07 | 108.61 | 99.81 | 275.78 | 13.43 | 84.03 | 233.55 | 5.94 |
| Quick ratioi | 2.07 | 106.73 | 74.04 | 119.97 | 5.14 | 16.15 | 20.15 | 4.59 |
| Debt / assetsi | 30.81 | 0.06 | 0.05 | 7.33 | 5.31 | 0.07 | 0.07 | 0.03 |
| LT debt / equityi | -- | 0.06 | 0.05 | 7.93 | 0.05 | 0.06 | 0.05 | 0.02 |
| Interest coveragei | -0.11 | -1.35 | -- | -7.93 | -2.58 | 862.89 | -293.89 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 0.00 | -- | -- | -- | 164.15 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -1.97 | -0.69 | 0.15 | 1.27 | 15.30 | 9.52 |
| ROA %i | -1.96 | -0.69 | 0.15 | 1.27 | 13.70 | 5.21 |
| ROIC %i | -2.11 | -0.80 | 0.01 | 1.07 | 14.74 | 5.98 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -33.92 | -3.67 | 0.83 | 6.50 | 29.23 | 35.84 |
| FCF / sales %i | -- | 29.72 | 74.62 | 67.52 | 95.05 | 97.04 |
| Current ratioi | 233.55 | 201.73 | 265.74 | 325.28 | 5.94 | 0.88 |
| Quick ratioi | 20.15 | 41.76 | 80.55 | 139.71 | 4.59 | 0.51 |
| Debt / assetsi | 0.07 | 0.07 | 0.06 | 0.04 | 0.03 | 31.01 |
| LT debt / equityi | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | 56.33 |
| Interest coveragei | -293.89 | -105.36 | 19.57 | 229.77 | -- | 153.95 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Acquiring and assembling a portfolio of uranium royalties, investing in companies with exposure to100.00%
Quote time 2026-10-08 06:33:07 · For reference only, not investment advice and not tailored to your situation.